MetroHealth Medical Center
MetroHealth's main campus administers IV Tylenol as part of its pain management protocol for elective tonsillectomy/adenoidectomy, whereas Parma campus does not. Comparing these practices provides an opportunity to evaluate the benefits of IV Tylenol for pain, agitation, and associated secondary outcomes in this population. The pain/agitation would be assessed with a validated tool PAED and FLACC
Inclusion Criteria: * Subjects pediatric patients aged ≤7 years, observed by study team who will complete the scales * Undergoing elective tonsillectomy and adenoidectomy. Exclusion Criteria: * Pre-existing neurological or developmental disorders impacting pain/agitation scores
No Intervention: Observational Cohort
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.